• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开启化疗成功之路:扩散张量成像在乳腺癌治疗中的作用

Unlocking Chemotherapy Success: The Role of Diffusion Tensor Imaging in Breast Cancer Treatment.

作者信息

Ciurea Anca Ileana, Bene Ioana, Cheregi Paul, Brad Thea, Ciortea Cristiana Augusta, Rusu Georgeta Mihaela, Ciule Larisa Dorina, Deac Andrada-Larisa, Lenghel Manuela Lavinia

机构信息

Department of Radiology, Faculty of Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Department of Radiology, Emergency County Hospital, 400006 Cluj-Napoca, Romania.

出版信息

Diagnostics (Basel). 2024 Nov 24;14(23):2650. doi: 10.3390/diagnostics14232650.

DOI:10.3390/diagnostics14232650
PMID:39682558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11639939/
Abstract

This study investigates the role of Diffusion Tensor Imaging (DTI) in predicting the response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer. A Diffusion Tensor Imaging magnetic resonance imaging (DTI MRI) sequence, evaluating water diffusion along tissue structures, was performed before and after two chemotherapy cycles. This study included 23 patients with 27 malignant masses, comparing changes in DTI parameters with Residual Cancer Burden (RCB) scores. : We found a significant correlation between changes in specific DTI parameters (e.g., λ2, FA, RA) and pathological response, suggesting that DTI could serve as a sensitive marker for early chemotherapy response. However, differences in sensitivity were observed between DTI sequences with 6 and 12 directions, indicating that 12-direction DTI may provide better diagnostic accuracy. The percentage change in DTI parameters, particularly FA, demonstrated a strong ability to predict pathological complete response (pCR) with high sensitivity. As a non-invasive tool, DTI has the potential to assess chemotherapy efficacy, although larger studies with standardized protocols are necessary to validate its clinical utility.

摘要

本研究探讨扩散张量成像(DTI)在预测局部晚期乳腺癌患者新辅助化疗(NAC)反应中的作用。在两个化疗周期前后,进行了评估沿组织结构水扩散的扩散张量成像磁共振成像(DTI MRI)序列。本研究纳入了23例患者的27个恶性肿块,将DTI参数的变化与残余癌负荷(RCB)评分进行比较。我们发现特定DTI参数(如λ2、FA、RA)的变化与病理反应之间存在显著相关性,表明DTI可作为早期化疗反应的敏感标志物。然而,观察到6方向和12方向DTI序列之间的敏感性存在差异,表明12方向DTI可能提供更好的诊断准确性。DTI参数的百分比变化,尤其是FA,具有以高敏感性预测病理完全缓解(pCR)的强大能力。作为一种非侵入性工具,DTI有潜力评估化疗疗效,尽管需要更大规模的标准化方案研究来验证其临床效用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/519f89f35424/diagnostics-14-02650-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/5b0eda87becd/diagnostics-14-02650-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/7508633199e3/diagnostics-14-02650-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/faeef9454903/diagnostics-14-02650-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/5a14fbd0b9f3/diagnostics-14-02650-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/3026bb06da98/diagnostics-14-02650-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/519f89f35424/diagnostics-14-02650-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/5b0eda87becd/diagnostics-14-02650-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/7508633199e3/diagnostics-14-02650-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/faeef9454903/diagnostics-14-02650-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/5a14fbd0b9f3/diagnostics-14-02650-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/3026bb06da98/diagnostics-14-02650-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b95/11639939/519f89f35424/diagnostics-14-02650-g006.jpg

相似文献

1
Unlocking Chemotherapy Success: The Role of Diffusion Tensor Imaging in Breast Cancer Treatment.开启化疗成功之路:扩散张量成像在乳腺癌治疗中的作用
Diagnostics (Basel). 2024 Nov 24;14(23):2650. doi: 10.3390/diagnostics14232650.
2
Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results.扩散张量成像对新辅助化疗乳腺癌反应的定量评估:初步结果。
J Magn Reson Imaging. 2018 Apr;47(4):1080-1090. doi: 10.1002/jmri.25855. Epub 2017 Sep 13.
3
Diagnostic performance of diffusion tensor imaging parameters in breast cancer and correlation with the prognostic factors.扩散张量成像参数在乳腺癌中的诊断效能及其与预后因素的相关性
J Magn Reson Imaging. 2017 Mar;45(3):660-672. doi: 10.1002/jmri.25481. Epub 2016 Sep 23.
4
Diffusion Tensor Imaging for Assessment of Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.扩散张量成像用于评估乳腺癌患者新辅助化疗的反应
Tomography. 2016 Dec;2(4):438-447. doi: 10.18383/j.tom.2016.00271.
5
Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.弥散张量成像用于表征肿瘤微结构并提高乳腺 MRI 的诊断性能:一项前瞻性观察研究。
Breast Cancer Res. 2019 Sep 4;21(1):102. doi: 10.1186/s13058-019-1183-3.
6
Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic Therapy.扩散张量成像在三阴性乳腺癌新辅助全身治疗期间评估变化的特征。
J Magn Reson Imaging. 2024 Oct;60(4):1367-1376. doi: 10.1002/jmri.29267. Epub 2024 Jan 31.
7
Comparison of the diagnostic performances of diffusion parameters in diffusion weighted imaging and diffusion tensor imaging of breast lesions.扩散加权成像和扩散张量成像中扩散参数对乳腺病变诊断性能的比较。
Eur J Radiol. 2013 Dec;82(12):e801-6. doi: 10.1016/j.ejrad.2013.09.001. Epub 2013 Sep 13.
8
Breast MRI during lactation: effects on tumor conspicuity using dynamic contrast-enhanced (DCE) in comparison with diffusion tensor imaging (DTI) parametric maps.哺乳期乳腺 MRI:动态对比增强(DCE)与扩散张量成像(DTI)参数图对肿瘤显示效果的比较。
Eur Radiol. 2020 Feb;30(2):767-777. doi: 10.1007/s00330-019-06435-x. Epub 2019 Sep 16.
9
Noncontrast Breast MRI During Pregnancy Using Diffusion Tensor Imaging: A Feasibility Study.妊娠期非对比增强乳腺 MRI 扩散张量成像:一项可行性研究。
J Magn Reson Imaging. 2019 Feb;49(2):508-517. doi: 10.1002/jmri.26228. Epub 2018 Aug 31.
10
Correlation of magnetic resonance diffusion tensor imaging and clinical findings of cervical myelopathy.磁共振弥散张量成像与颈椎病临床相关性研究。
Spine J. 2013 Aug;13(8):867-76. doi: 10.1016/j.spinee.2013.02.005. Epub 2013 Mar 21.

本文引用的文献

1
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.早期乳腺癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2024 Feb;35(2):159-182. doi: 10.1016/j.annonc.2023.11.016. Epub 2023 Dec 13.
2
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023.了解乳腺癌的复杂性以改善患者结局:2023 年圣加仑国际乳腺癌早期个体化治疗共识会议。
Ann Oncol. 2023 Nov;34(11):970-986. doi: 10.1016/j.annonc.2023.08.017. Epub 2023 Sep 6.
3
Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer.
评估乳腺癌新辅助化疗疗效的影像学进展
Front Oncol. 2022 May 20;12:816297. doi: 10.3389/fonc.2022.816297. eCollection 2022.
4
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.新辅助化疗后残余肿瘤负担与乳腺癌长期生存结局:5161 例患者的多中心汇总分析。
Lancet Oncol. 2022 Jan;23(1):149-160. doi: 10.1016/S1470-2045(21)00589-1. Epub 2021 Dec 11.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.扩散加权 MRI 表现预测乳腺癌新辅助治疗的病理反应:ACRIN 6698 多中心试验。
Radiology. 2018 Dec;289(3):618-627. doi: 10.1148/radiol.2018180273. Epub 2018 Sep 4.
7
Diffusion Tensor Imaging for Assessment of Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.扩散张量成像用于评估乳腺癌患者新辅助化疗的反应
Tomography. 2016 Dec;2(4):438-447. doi: 10.18383/j.tom.2016.00271.
8
Diffusion-weighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: A meta-analysis.扩散加权成像在识别乳腺癌对新辅助化疗的病理反应中的应用:一项荟萃分析。
Oncotarget. 2017 Dec 11;9(6):7088-7100. doi: 10.18632/oncotarget.23195. eCollection 2018 Jan 23.
9
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.新辅助化疗与辅助化疗治疗早期乳腺癌的长期疗效:来自十个随机试验的个体患者数据的荟萃分析。
Lancet Oncol. 2018 Jan;19(1):27-39. doi: 10.1016/S1470-2045(17)30777-5. Epub 2017 Dec 11.
10
Imaging Neoadjuvant Therapy Response in Breast Cancer.乳腺癌新辅助治疗反应的影像学评估。
Radiology. 2017 Nov;285(2):358-375. doi: 10.1148/radiol.2017170180.